Royalty Pharma plc (RPRX)
NASDAQ: RPRX · Real-Time Price · USD
36.37
+0.18 (0.50%)
At close: Jul 3, 2025, 1:00 PM
36.23
-0.14 (-0.38%)
After-hours: Jul 3, 2025, 4:20 PM EDT
Royalty Pharma Market Cap
Royalty Pharma has a market cap or net worth of $20.45 billion as of July 3, 2025. Its market cap has increased by 69.97% in one year.
Market Cap
20.45B
Enterprise Value
26.97B
1-Year Change
69.97%
Ranking
Category
Stock Price
$36.37
Market Cap Chart
Since June 16, 2020, Royalty Pharma's market cap has increased from $15.76B to $20.45B, an increase of 29.74%. That is a compound annual growth rate of 5.29%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 3, 2025 | 15.33B | 35.21% |
| Dec 31, 2024 | 11.33B | -9.30% |
| Dec 29, 2023 | 12.50B | -28.31% |
| Dec 30, 2022 | 17.43B | 1.85% |
| Dec 31, 2021 | 17.12B | -11.89% |
| Dec 31, 2020 | 19.43B | 23.26% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 697.52B |
| Johnson & Johnson | 374.91B |
| AbbVie | 334.20B |
| Novo Nordisk | 309.43B |
| UnitedHealth Group | 281.55B |
| Novartis AG | 243.28B |
| Abbott Laboratories | 233.05B |
| AstraZeneca | 219.33B |